Evidence map›Paper›PMID 41377403›Full record

ArticleAnnals of medicine and surgery (2012)2025

Radiotherapy in Nigeria: a silent emergency in cancer care.

Adeleke Oluwaseun Dorcas, Ikeoluwa Oluwapelumi Ayoola, Divine Besong Arrey Agbor, Toluwalase Awoyemi

Abstract readEditorial
In one paragraph

Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adeleke Oluwaseun DorcasFaculty of Medicine, Sumy State University, Sumy, Ukraine.ORCID https://orcid.org/0009-0004-0893-2491
Ikeoluwa Oluwapelumi AyoolaBowen University Teaching Hospital, Iwo, Nigeria.
Divine Besong Arrey AgborHematology and Oncology Fellowship, Guthrie Hospital/Robert Parker Hematology and Oncology Fellowship, Sayre, PA, USA.
Toluwalase AwoyemiDivision of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy (RT) remains an essential component of modern cancer management, both for cure and palliation, yet access across Nigeria continues to lag far behind global standards. Despite being Africa's most populous nation, Nigeria has only a handful of functional RT machines, with frequent breakdowns, erratic power supply, and inadequate maintenance crippling service delivery. Many patients are forced to wait weeks or months for treatment, often with disease progression during the delay. Of the eight government-funded RT centers, only two consistently treat patients with functional linear accelerators. At the same time, most rely on outdated 2D techniques and lack imaging support such as CT or MRI simulators. The shortage of trained personnel exacerbates the crisis: the country lacks clinical residency programs for medical physicists, offers limited opportunities for continuing education, and has an insufficient number of radiation oncologists to meet the growing cancer burden. These limitations not only reduce treatment capacity but also deepen inequities in cancer outcomes, as timely RT becomes a privilege for a few rather than a standard of care. Improving access demands sustained investment, transparent procurement, regular maintenance, and workforce development. International collaboration, public-private partnerships, and strong political will are critical to reversing decades of neglect. The current state of RT in Nigeria is more than a technical shortfall; it is a silent emergency in cancer care that demands immediate attention, strategic planning, and committed implementation.

Indexed as

AfricaNigeriaOncology emergencyRadiotherapyRadiotherapy equipment

Identifiers

PMID41377403
PMCPMC12688764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.